CNS Pharmaceuticals logo

CNS Pharmaceuticals

CNSP | NASDAQ
Chart Builder DCF Calculator
$3.48
+$0.59 (+20.42%)
At close: Nov 16, 2026, 4:00 PM ET
$3.60
+$0.12 (+3.45%)
After-hours: Nov 16, 2026, 5:54 PM ET
+20.42%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
29.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #826/1021 (Top 81%)

Key Statistics

Market Data

Market Cap $5.09M
1D Range
2.96 3.55
52W Range
2.13 7.84

Valuation (TTM)

PE -0.15
PB 0.28
EV/EBITDA 0.89

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $0.50
Loading financial charts...

Profile

CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primar...

Sector Healthcare
Industry Biotechnology
Employees 8
IPO Date Nov 8, 2019
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.